Target- |
MechanismVirus replication inhibitors |
|
|
|
|
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Antivirus Therapeutics, Inc.
0 Patents (Medical) associated with Antivirus Therapeutics, Inc.
100 Deals associated with Antivirus Therapeutics, Inc.
100 Translational Medicine associated with Antivirus Therapeutics, Inc.